GMP IPO Watch
NJ Momentum Fund
Direct Plan · Growth Option · NJ Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +0.51% | -0.06% | 89 of 255 |
| 1M | -3.63% | -4.39% | 68 of 253 |
| YTD | -2.09% | -0.62% | 121 of 255 |
| INCEPTION | -10.88% | — | — |
Ranked among: Equity Scheme - Sectoral/ Thematic.
NAV History
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity99.65%
- Debt0.00%
- Cash0.35%
- Other0.00%
Market Cap Split
- Large Cap27.99%
- Mid Cap37.78%
- Small Cap33.90%
- Others0.33%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 28.68 | 28.91 |
| P/B | 5.06 | 4.70 |
| Price / Sales | 5.20 | 3.41 |
| Price / Cash Flow | 30.28 | 21.65 |
| Dividend Yield (%) | 0.99 | 1.17 |
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| Welspun Corp | Industrial Products | 6.72% | +1.04% |
| MCX | Capital Markets | 4.68% | +0.05% |
| Kirloskar Oil Engines | Industrial Products | 4.30% | +0.54% |
| Laurus Labs | Pharmaceuticals & Biotechnology | 4.22% | +0.30% |
| Titan | Consumer Durables | 3.84% | -0.26% |
| Torrent Pharmaceuticals | Pharmaceuticals & Biotechnology | 3.63% | -0.05% |
| Shriram Finance | Finance | 3.58% | -0.31% |
| Bharat Forge | Auto Components | 3.57% | -0.18% |
| Federal Bank | Banks | 3.38% | -0.26% |
| Lupin | Pharmaceuticals & Biotechnology | 3.26% | -0.11% |
| Navin Fluorine International | Chemicals & Petrochemicals | 2.78% | -0.03% |
| Sona BLW Precision Forgings | Auto Components | 2.75% | +0.16% |
| Aditya Infotech | Industrial Manufacturing | 2.74% | +0.30% |
| Phoenix Mills | Realty | 2.61% | +0.15% |
| Belrise Industries | Auto Components | 2.59% | +0.19% |
View all 42 holdings
| Radico Khaitan | Beverages | 2.57% | +0.04% |
| Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.56% | +0.03% |
| Acutaas Chemicals | Pharmaceuticals & Biotechnology | 2.56% | +0.19% |
| Granules | Pharmaceuticals & Biotechnology | 2.49% | +0.15% |
| RR Kabel | Industrial Products | 2.47% | -0.29% |
| Bajaj Auto | Automobiles | 2.41% | -0.17% |
| Union Bank of India | Banks | 2.38% | -0.14% |
| Eicher Motors | Automobiles | 2.33% | -0.16% |
| Himadri Speciality Chemical | Chemicals & Petrochemicals | 2.30% | +0.15% |
| Marico | Agricultural Food & other Products | 2.30% | -0.01% |
| ABB | Electrical Equipment | 2.30% | -0.19% |
| Karur Vysya Bank | Banks | 2.26% | -0.07% |
| State Bank of India | Banks | 2.23% | -0.13% |
| Cummins | Industrial Products | 2.20% | -0.07% |
| L&T Finance | Finance | 2.03% | -0.33% |
| Samvardhana Motherson International | Auto Components | 1.11% | +0.00% |
| Solar Industries | Chemicals & Petrochemicals | 1.09% | +0.02% |
| RBL Bank | Banks | 1.03% | +0.10% |
| Zydus Life Science | Pharmaceuticals & Biotechnology | 1.00% | +0.04% |
| Oracle Financial Services Software | IT - Software | 0.97% | -0.13% |
| Bank of Maharashtra | Banks | 0.96% | +0.01% |
| NMDC | Minerals & Mining | 0.92% | -0.10% |
| Nestle | Food Products | 0.89% | -0.08% |
| Jammu & Kashmir Bank | Banks | 0.85% | -0.02% |
| Manappuram Finance | Finance | 0.81% | -0.03% |
| Clearing Corporation of India Ltd | Net Current Assets | 0.67% | — |
| Net Receivables / (Payables) | Net Current Assets | -0.32% | — |
Sector Allocation · Sep 2026
View all 17 sectors
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Nippon India Taiwan Equity Fund
Regular Plan · IDCW option
|
+124.77% | +60.05% | — | +31.88% |
|
Franklin Asian Equity Fund
Regular Plan · IDCW
|
+27.89% | +21.51% | +5.47% | +4.27% |
|
Nippon India Japan Equity Fund
Regular Plan · Bonus Option
|
+27.88% | +22.63% | +10.31% | +9.06% |
|
Motilal Oswal Active Momentum Fund
Direct Plan · Growth
|
+25.42% | — | — | +27.64% |
|
HDFC Pharma and Healthcare Fund
Direct Plan · IDCW Option
|
+23.23% | +29.29% | — | +29.18% |
|
Kotak Healthcare Fund
Regular Plan · IDCW Option
|
+22.42% | — | — | +19.41% |
|
PGIM India Healthcare Fund
Direct Plan · Direct IDCW
|
+20.96% | — | — | +10.67% |
|
Edelweiss Recently Listed IPO Fund
Regular Plan · Growth
|
+20.82% | +16.27% | +9.45% | +14.84% |
|
Motilal Oswal Special Opportunities Fund
Direct Plan · Growth
|
+19.22% | — | — | +19.96% |
|
HSBC India Export Opportunities Fund
Direct Plan · Growth
|
+17.60% | — | — | +8.04% |
More From NJ Asset Management Private Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
NJ Arbitrage Fund
Direct Plan · Growth Option
|
+6.29% | +6.77% | — | +6.82% |
|
NJ Overnight Fund
Direct Plan · Growth Option
|
+5.19% | +5.97% | — | +6.06% |
|
NJ Balanced Advantage Fund
Direct Plan · IDCW Payout Option
|
-1.95% | +7.52% | — | +7.14% |
|
NJ ELSS Tax Saver Fund
Direct Plan · IDCW Payout Option
|
-4.94% | +8.25% | — | +10.81% |
|
NJ Flexi Cap Fund
Direct Plan · IDCW Payout Option
|
-6.44% | +8.69% | — | +8.49% |
|
NJ Value Fund
Regular Plan · Growth Option
|
— | — | — | -43.22% |
About This Scheme
Investment Objective
The investment objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related instruments of companies that exhibit strong momentum. However, there is no assurance or guarantee that the investment objective of the scheme will be achieved.
Stated Asset Allocation
Instruments Indicative allocations (% of total assets) Equity and Equity related instruments of companies selected based on momentum theme Minimum 80% - Maximum 100% Risk Profile – Medium to High Equity and Equity related instruments of companies selected based on themes other than momentum theme Minimum 0% - Maximum 20% Risk Profile – Medium to High Money market instruments, other liquid instruments, InvITs, Gold and Silver instruments and other permissible securities approved by SEBI from time to time Minimum 0% - Maximum 20% Risk Profile - Low to Medium
Exit Load
Nil
Fund Managers
Mr. Dhaval Patel, Mr. Viral Shah and Mr. Jaimin Ilavia
Primary
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.